Confirmation of calcium absorption promoting action in mannooligosaccharides
- Conditions
- Healthy adult
- Registration Number
- JPRN-UMIN000046111
- Lead Sponsor
- KSO Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 30
Not provided
(1)Subjects who affected from chronic illness and are taking drugs (2)Subjects who have bone-related diseases (3)Subjects who have a medical history of diseases such as malignant tumor, heart failure, myocardial infarction, arrhythmia, liver dysfunction, cerebrovascular disease, rheumatism, diabetes, dyslipidemia, hypertension, urinary stones, etc. (4)Subjects who are taiking supplements (including foods for specified health use and foods with functional claims) (5)Subjects who regularly drink milk (6)Subjects working in night shifts (7)Subjects who who always have diarrhea (8)Subjects who have a history of gastrointestinal disorders and gastrointestinal surgery that affect gastrointestinal absorption (9)Subjects who have allergies to food ingredients contained in test foods (10)Subjects who are pregnant, breastfeeding, or willing to become pregnant (11)Subjects who have collected more than 200 mL of blood within 12 weeks prior to the screening test (12)Subjects who participate in other clinical trials (food, pharmaceuticals and cosmetics), who have participated in other tests within one month of obtaining consent, or who are willing to participate (13)Subjects who are judged as unsuitable for the study by the investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Excreted urinary calcium
- Secondary Outcome Measures
Name Time Method rinary deoxypyridinoline Urinary NTx